News

Blackman Industries, Inc. of Kansas City, KS is recalling all PrimeTime brand 2 ct. and 5 ct. Premium Pig Ears and all KC Beefhide brand 20 ct. Premium Pig Ears because they have the potential to be contaminated with Salmonella. These products were sold in Kansas, Missouri, Iowa, Nebraska and South Dakota.

The FDA’s Center for Veterinary Medicine is alerting pet owners to use caution with the use of an unapproved animal drug product, Douxo Seborrhea Shampoo (0.1% phytosphingosine), distributed by Sogeval Laboratories, Inc. of Coppell, Texas after recently receiving a report of the death of a woman associated with the use of the product on her dog.

Triad Group, a manufacturer of over-the-counter products has initiated a voluntary product recall involving all lots of Alcohol Prep Pads, Alcohol Swabs or Alcohol Swabsticks manufactured by Triad Group which may be included in a variety of other products labeled with other manufacturers' names.

American Regent is conducting a nationwide voluntary recall of Ammonium Molybdate Injection, USP (Molybdenum 250mcg/10mL) 10mL Single Dose Vial NDC 0517-6610-25, Lot # 9409, Exp. Date June 2011. This recall was initiated on April 26, 2011 to the User Level for Lot # 9409 only. No other lots of Ammonium Molybdate Injection, USP are subject to this recall.

Greenstone LLC announced a recall of medicines with lot number FI0510058-A on the label. Bottles labeled as Citalopram (used to treat depression) may contain Finasteride (used for the treatment of benign prostatic hyperplasia).

The Food and Drug Administration’s Center for Veterinary Medicine (CVM) has become aware of a human drug recall for Phenobarbital tablets. Phenobarbital is prescribed by veterinarians as an extralabel use for treating seizures in animals.

H&P industries, Inc., a manufacturer of over-the-counter products has initiated a voluntary product recall of all lots of Povidine Prep Pads manufactured by H&P Industries, Inc. but which are private labeled for many accounts.

This recall was initiated because some of the vials of these lots may contain visible particulates. Potential adverse events after intravenous administration of solutions containing particulates may include disruption of blood flow within small blood vessels in the lung, localized inflammation (swelling and redness due to accumulation of inflammatory cells), and granuloma formation.